Hydrogenetics, Inc. (HYGN)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Hydrogenetics, Inc. (HYGN) trades at $0.00 with AI Score 46/100 (Grade C). Hydrogenetics, Inc. is a specialty chemicals company focused on hydrogen generation systems and biodiesel production. Market cap: $36,326, Sector: Basic materials.
Last analyzed: Mar 16, 2026Analyst Coverage for HYGN: HYGN does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates HYGN against Basic Materials peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
HYGN: the 1 perspectives are evenly split.
Hydrogenetics, Inc. (HYGN) Materials & Commodity Exposure
Hydrogenetics, Inc. leverages its innovative hydrogen generating systems and biodiesel production capabilities to serve various global markets, positioning itself as a unique player in the specialty chemicals sector.
What Is the Investment Thesis for HYGN?
Hydrogenetics, Inc. presents a unique investment thesis driven by its focus on hydrogen generation and biodiesel production. The global hydrogen market is projected to grow significantly, with estimates suggesting a compound annual growth rate (CAGR) of over 14% through 2025, driven by increasing demand for clean energy solutions. Hydrogenetics' proprietary technology in hydrogen systems positions it well to capitalize on this trend. Additionally, the biodiesel market is also expanding, with a growing emphasis on sustainable fuel sources. The company's ability to source waste vegetable oil and convert it into biodiesel presents a sustainable revenue stream. However, investors should be aware of potential risks, including market competition and regulatory changes affecting the renewable energy sector. The company's current market cap is $0.00B, indicating a need for strategic growth initiatives to enhance its valuation.
Based on FMP financials and quantitative analysis
HYGN Key Highlights
- Market Cap: $0.00B, indicating a need for growth and strategic initiatives.
- Beta: -42.99, suggesting a unique volatility profile compared to the market.
- Focus on hydrogen generation systems, tapping into a rapidly growing market.
- Diversified revenue streams through biodiesel production and film production.
- Small employee base of 1, indicating potential for operational scaling.
Who Are HYGN's Competitors?
HYGN is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| LWLG Lightwave Logic, Inc. | $9.57 | -4.68% | $1.47B | 69 |
| HGRAF HydroGraph Clean Power Inc. | $5.00 | +0.81% | $1.70B | 69 |
| COOSF Carbios SAS | $8.61 | +0.00% | $145.26M | 69 |
| ICHMF ISE Chemicals Corporation | $24.73 | +0.00% | $1.26B | 62 |
| MITUY Mitsui Chemicals, Inc. | $11.21 | +0.00% | $4.13B | 49 |
| PPG PPG Industries, Inc. | $119.13 | +0.75% | $26.55B | 49 |
| ASGLY AGC Inc. | $8.71 | +0.58% | $9.25B | 49 |
| SXT Sensient Technologies Corporation | $123.75 | -0.35% | $5.27B | 49 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are HYGN's Key Strengths?
- Innovative hydrogen generation technology.
- Diversified business model with multiple revenue streams.
- Established presence in the biodiesel market.
What Are HYGN's Weaknesses?
- Limited employee base may hinder scalability.
- Current market cap of $0.00B indicates potential financial challenges.
- Dependence on the success of subsidiaries for revenue.
What Could Drive HYGN Stock Higher?
- Expansion of hydrogen generation technology into new markets.
- Development of biodiesel production capabilities from waste sources.
- Strategic partnerships with automotive manufacturers.
What Are the Key Risks for HYGN?
- Regulatory changes impacting renewable energy markets.
- Competitive pressures from established players in hydrogen and biodiesel.
- Market volatility affecting demand for specialty chemicals.
What Are the Growth Opportunities for HYGN?
- Growth opportunity 1: The global hydrogen market is expected to reach $200 billion by 2025, driven by increasing adoption in transportation and industrial applications. Hydrogenetics' innovative hydrogen generating systems could capture a significant share of this expanding market, particularly as governments worldwide push for cleaner energy solutions.
- Growth opportunity 2: The biodiesel market is projected to grow at a CAGR of 5.5% from 2021 to 2028, fueled by rising demand for renewable fuels. Hydrogenetics' ability to source waste vegetable oil and produce biodiesel positions it well to benefit from this trend, especially as more companies seek sustainable fuel alternatives.
- Growth opportunity 3: Expansion into international markets presents a substantial growth avenue for Hydrogenetics. As countries implement stricter emissions regulations and seek alternative energy sources, the demand for hydrogen systems and biodiesel is likely to increase, allowing Hydrogenetics to expand its geographical reach.
- Growth opportunity 4: Strategic partnerships with automotive and industrial manufacturers could enhance Hydrogenetics' market presence. Collaborating with established companies in the automotive sector to integrate hydrogen systems into their vehicles could accelerate adoption and drive revenue growth.
- Growth opportunity 5: The increasing focus on environmental sustainability among consumers and businesses creates a favorable market environment for Hydrogenetics. As awareness of climate change and the need for cleaner energy solutions grows, the demand for hydrogen and biodiesel products is expected to rise, providing a strong growth trajectory for the company.
What Opportunities Does HYGN Have?
- Growing global demand for hydrogen and biodiesel.
- Potential for strategic partnerships in automotive and industrial sectors.
- Expansion into international markets.
What Threats Does HYGN Face?
- Intense competition from established players in the hydrogen and biodiesel sectors.
- Regulatory changes impacting renewable energy markets.
- Market volatility affecting demand for specialty chemicals.
What Are HYGN's Competitive Advantages?
- Innovative technology in hydrogen generation provides a competitive edge.
- Diversified revenue streams reduce dependency on a single market.
- Sustainable sourcing of raw materials for biodiesel production enhances credibility.
What Does HYGN Do?
Founded in 1996, Hydrogenetics, Inc. has evolved from its original identity as Global Entertainment Acquisition Corp. to a company focused on hydrogen generation and biodiesel production. The company operates through its subsidiary, HydroAxis Technologies, Inc., which develops hydrogen generating systems applicable to gas and diesel internal combustion engines across multiple sectors, including automotive, marine, and military. Hydrogenetics also owns Pacific Lights Entertainment, Inc., a film production company that creates small-budget films primarily in the comedy and Sci-Fi genres. Additionally, through Buffalo Biodiesel Inc., it sources waste vegetable oil from food establishments and resells it as raw feedstock to biodiesel refineries, while also producing and selling biodiesel and yellow grease. This diversified portfolio allows Hydrogenetics to tap into both the renewable energy and entertainment markets, although it primarily focuses on sustainable energy solutions. The company is headquartered in Fort Lauderdale, Florida, and aims to leverage its innovative technologies to address the growing demand for cleaner energy alternatives in various industries.
What Products and Services Does HYGN Offer?
- Develop hydrogen generating systems for gas and diesel engines.
- Produce biodiesel from waste vegetable oil sourced from food establishments.
- Operate a film production company focused on small-budget comedies and Sci-Fi films.
- Sell biodiesel and yellow grease to companies in the U.S. and internationally.
- Provide innovative energy solutions for various markets including automotive and military.
How Does HYGN Make Money?
- Revenue generated from the sale of hydrogen generating systems.
- Income from biodiesel production and sales to refineries.
- Film production revenues from Pacific Lights Entertainment, Inc.
- Sourcing and reselling waste vegetable oil for biodiesel production.
What Industry Does HYGN Operate In?
The specialty chemicals industry is experiencing a shift towards sustainable and renewable energy solutions, driven by global initiatives to reduce carbon emissions. The hydrogen market, in particular, is gaining traction as a clean energy alternative, with significant investments being made in hydrogen infrastructure and technology. Competitors in this space, including ABZUF, AMNL, AMNZF, GDPEF, and GTBT, are also focusing on innovative solutions to meet the rising demand for environmentally friendly energy sources. Hydrogenetics, with its dual focus on hydrogen systems and biodiesel, is strategically positioned to leverage these industry trends, although it faces competition from established players with more resources.
Who Are HYGN's Key Customers?
- Automotive manufacturers seeking hydrogen solutions.
- Biodiesel refineries in need of raw feedstock.
- Film distribution companies for comedy and Sci-Fi genres.
- Commercial food establishments providing waste vegetable oil.
HYGN Latest News
No recent news available for HYGN.
HYGN Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for HYGN.
Price Targets
Wall Street price target analysis for HYGN.
HYGN MoonshotScore
What does this score mean?
The MoonshotScore rates HYGN's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Charles W. Hansen III
CEO
Charles W. Hansen III has been leading Hydrogenetics, Inc. since its inception. With a background in engineering and business management, he has a strong track record in developing innovative technologies and guiding companies through transitions in the energy sector.
Track Record: Under Hansen's leadership, Hydrogenetics has focused on diversifying its business model and enhancing its technological capabilities, positioning the company to capitalize on emerging trends in renewable energy.
HYGN OTC Market Information
The OTC Other tier includes companies that do not meet the requirements for higher tiers like OTCQX or OTCQB. These companies may have less stringent reporting requirements and may not be as widely followed by analysts, which can lead to lower liquidity and higher volatility.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosures compared to companies on major exchanges.
- Potential for higher volatility and lower liquidity.
- Increased risk of fraud or mismanagement in lower-tier OTC companies.
- Verify the company's financial statements and disclosures.
- Assess the management team's experience and track record.
- Evaluate the competitive landscape and market position.
- Review any recent news or developments affecting the company.
- Understand the company's business model and revenue sources.
- Established history since 1996.
- Diverse business operations across hydrogen, biodiesel, and entertainment.
- Presence of a qualified management team.
HYGN Basic Materials Stock FAQ
What does Hydrogenetics, Inc. do?
Hydrogenetics, Inc. specializes in developing hydrogen generating systems for gas and diesel engines, catering to various markets including automotive and military. Additionally, it produces biodiesel from waste vegetable oil and operates a film production company, diversifying its revenue streams.
What do analysts say about HYGN stock?
Analysts have noted Hydrogenetics' unique positioning in the specialty chemicals sector, particularly its focus on hydrogen and biodiesel. However, the company's low market cap and limited financial disclosures may raise concerns about its growth potential and market competitiveness.
What are the main risks for HYGN?
Key risks for Hydrogenetics include regulatory changes that could impact the renewable energy sector, competitive pressures from larger players in the hydrogen and biodiesel markets, and potential market volatility affecting demand for specialty chemicals. Investors may want to evaluate these factors when evaluating the company's prospects.
What are the key factors to evaluate for HYGN?
Hydrogenetics, Inc. (HYGN) holds an AI score of 46/100 (low). Not financial advice.
How frequently does HYGN data refresh on this page?
HYGN prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven HYGN's recent stock price performance?
Hydrogenetics, Inc. (HYGN) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Innovative hydrogen generation technology. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider HYGN overvalued or undervalued right now?
Valuing Hydrogenetics, Inc. (HYGN) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying HYGN?
Before investing in Hydrogenetics, Inc. (HYGN), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited financial data available due to OTC classification.